Compare RVYL & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVYL | PAVM |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 8.5M |
| IPO Year | N/A | 2016 |
| Metric | RVYL | PAVM |
|---|---|---|
| Price | $6.31 | $8.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 838.4K | ★ 2.9M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,858,000.00 | $29,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $297.49 | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 29.50 | N/A |
| 52 Week Low | $4.50 | $6.00 |
| 52 Week High | $81.55 | $28.44 |
| Indicator | RVYL | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 65.03 | 55.53 |
| Support Level | $5.30 | $7.47 |
| Resistance Level | $7.68 | $10.55 |
| Average True Range (ATR) | 1.03 | 2.26 |
| MACD | -0.02 | -0.35 |
| Stochastic Oscillator | 39.58 | 7.12 |
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.